Navigation Links
TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers
Date:3/4/2010

ANDOVER, Mass., March 4 /PRNewswire/ -- TransMedics, Inc., a leading medical device company focusing on delivering the next standard of care for solid organ transplantation worldwide, announced today the closing of a $36 million financing round. The financing was lead by Foundation Capital and Kleiner Perkins Caufield & Byers (KPCB) and also included investments by Flagship Ventures and by several existing investors.

TransMedics is the maker of the Organ Care System (OCS™).  The OCS™ is a breakthrough technology platform, which maintains donor organs in near-physiologic and functioning condition during transport for organ transplantation.  The OCS™ has the potential to significantly improve post-transplant clinical outcomes and expand the number of transplant procedures performed annually based on its unique and proprietary capabilities to overcome the current challenges of cold storage approach to donor organs.  The OCS™ platform has been recognized by the Cleveland Clinic Foundation as one of the Top 10 Medical Innovations for 2009, and by CNN as one of the Top 10 Healthcare Innovations of 2009.  In addition, OCS™ technology was featured in the February, 2007 issue of National Geographic magazine in an article titled "Mending Broken Hearts."  The article discussed the latest and most promising medical technologies to address the growing heart failure epidemic.

"We are excited at the high level of confidence our investors have in our transforming technology and market potential," said Dr. Waleed Hassanein, President and CEO of TransMedics, Inc.  "This financing enables us, over the next two years, to expand our commercial presence into the US market with our heart OCS™ device and to globally launch the OCS™ lung device."

"All of us at Foundation are thrilled to be part of such a high quality company and investor syndicate.  TransMedics' OCS™ system can positively impact the quality of life for thousands of people each year, and will fundamentally change the way society thinks about organ transplantation.  We are proud to play a small role in their team's road to commercial success," said Mr. Adam Grosser, General Partner, Foundation Capital.  

"The field of solid organ transplantation is undergoing revolutionary advances, and TransMedics is positioned to emerge as the world leader in the field.  We at Kleiner Perkins are extremely motivated to invest in companies that matter, that improve peoples lives in a significant way -- TransMedics clearly meets that criteria," said Mr. Joe Lacob, Partner, KPCB.

About TransMedics, Inc.:  TransMedics is a privately held medical technology company dedicated to extending the life saving benefits of organ transplantation to patients suffering from end-stage organ failure.  Headquartered in Andover, Massachusetts, the company was founded in 1998 to address the unmet need for more and better organs for transplants. For more information, please visit www.TransMedics.com.

About Foundation Capital:  Founded in 1995, Foundation Capital is a venture capital firm committed to supporting entrepreneurs and their companies, targeting innovative opportunities in cleantech, consumer Internet and infrastructure; telecommunications and networking; and enterprise software and on demand services. Foundation Capital funds total more than $2.4 billion. For more information, please visit www.foundationcapital.com.

About Kleiner Perkins Caufield & Byers:  Since its founding in 1972, Kleiner Perkins Caufield & Byers has backed entrepreneurs in over 500 ventures, including AOL, Amazon.com, Citrix, Compaq Computer, Electronic Arts, Genentech, Genomic Health, Google, Intuit, Juniper Networks, Netscape, Lotus, Sun Microsystems, Symantec, Verisign and Xilinx. KPCB portfolio companies employ more than 250,000 people. More than 150 of the firm's portfolio companies have gone public. Many other ventures have achieved success through mergers and acquisitions. The firm has offices in Menlo Park, California; Beijing, China; and Shanghai, China.  For additional information visit please visit www.kpcb.com.

SOURCE TransMedics, Inc.

Back to top

RELATED LINKS
http://www.TransMedics.com

'/>"/>

SOURCE TransMedics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital
3. HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing
4. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
5. ALung Secures $2.5 Million
6. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
7. Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
8. GeoVax Secures $10 Million Financing Commitment
9. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
10. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
11. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Nov. 29, 2016 Several leading ... by Accera, Inc. at 11 a.m. EST ... International Conference on Clinical Trials for Alzheimer,s Disease (CTAD). ... metabolism in Alzheimer,s disease and therapeutic targets that address ... "Following the recent failure of another therapy targeting ...
(Date:12/5/2016)... DUBLIN , Dec 5, 2016 ... Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, ... Companies) - Global Forecasts to 2021" report to their offering. ... , , ... reach USD 730.7 Million in 2021 from USD 574.8 Million in ...
(Date:12/5/2016)... and PUNE, India , December 5, 2016 /PRNewswire/ ... titled, "Surgical Sutures Market by Product Type and by Application - Global Opportunity ... for $3,360 million in 2015, and is expected to reach $5,255 million by ... segment dominated the market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 2016 , ... Just in time for the holiday season, the celebrated paleo ... for Honeyville’s new Organic Quinoa Flour product for sale at Costco stores throughout the ... , “I think it’s wonderful that a growing number of retailers such as ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement ... of the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of a powerful woman's story of sacrifice and enlightenment. , “Tatiana ... author, Carolyn Fryer. Always looking for creative outlets, Carolyn gravitated toward writing through ...
(Date:12/6/2016)... ... December 06, 2016 , ... The OSHA Training Center ... Education Center headquartered in Northern California, has announced the addition of a Public ... health training to public sector employees. , “The primary goal of the Public ...
(Date:12/5/2016)... ... 05, 2016 , ... What: Shriners Hospitals for Children, with the help of ... – using a video monitor and web-enabled camera. Santa visits with children through Dimension ... a Christmas Wonderland, which is where the video connection to the North Pole will ...
Breaking Medicine News(10 mins):